Asthma and COPD are common obstructive lung diseases that affect a large portion of the population. Although they share similar symptoms, their underlying pathophysiology differs, requiring distinct treatment strategies. Advances in biologic therapies underscore the importance of pulmonologists having a deeper understanding of lung immunobiology. This Rapid Recap will address knowledge gaps in immunology, helping pulmonologists use biologics more effectively in clinical practice.